Welcome to the website of DSM Sinochem Pharmaceuticals!

DSM Sinochem Pharmaceuticals (DSP) is the global leader in sustainable antibiotics, next generation statins and anti-fungals.

We develop, produce and sell raw materials, intermediates, active pharmaceutical ingredients (API) and drug products (DP).

Our employees worldwide work together to deliver cutting edge generics solutions that help to keep customers ahead of the

Headquartered in Singapore, the group has operations in China, India, Egypt, the Netherlands, Spain, the US and Mexico.


DSM Sinochem Pharmaceuticals today announced that it has completed construction of a world-class statins plant  in Toansa, India. Production of atorvastatin started  in the second half of 2014, using DSP’s proprietary enzymatic (bio)technology route. The new plant is included in the updated CEP (CEP 2010-366, revision 2) for Atorvastatin Calcium from DSP. Readmore

DSP supports fight against superbugs and welcomes the recommendations of the AMR Review.

DSM Sinochem Pharmaceuticals (DSP) welcomes the final report of Lord O’Neill’s global AMR Review, which lists concrete interventions to fight antimicrobial resistance (AMR) and the drug resistant superbugs it creates. DSP fully supports these measures. Guided by its brand promise “Quality. Reliability. Sustainability.”, DSP has been advocating for more transparency in the value chain and to stop irresponsible production of antibiotics. In line with the AMR Review recommendations, DSP is promoting the use of the best and cleanest available technology, dedicated waste water treatment plants and antimicrobial activity testing, to ensure clean and high quality production. Readmore

DSP publishes Sustainability Report 2014.


DSM Sinochem Pharmaceuticals (DSP) issues the 2014 Sustainability Report, inspired by the GRI framework. The Report gives an overview of DSP's business and sustainability performance and DSP's efforts on Sustainable Antibiotics. 

Karl Rotthier, CEO of DSP, highlighted the importance of antibiotics for mankind and our responsibility to ensure that these life-saving drugs remain effective and are thus produced responsibly. Readmore